Course Objectives

1) Review current findings with regard to awareness, treatment, and control of disease condition 2) Understand drug treatment recommendations 3) Relate findings to changes in treatment in clinical practice

Approved on: January 27, 2010
Expires on: January 27, 2011

Up to 1.0 credit hours are possible for this course. To qualify for credits, the course assessment and post-survey must be completed. The links to these are located next to the course item in the table below:

Credits	Article	Assessment
1.0	Adjuvant chemotherapy in older women with early-stage breast cancer.	Take assessment
	Requisite post-assessment survey.	Take survey
This CME program will expire on January 27, 2011.

After you have completed the assessment and survey, to claim credits, view your transcript here.

Accreditation

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the XYZ University Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation

XYZ University Center for Continuing Education designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Disclosure

It is the policy of the XYZ University Center for Continuing Education to plan and implement all of its educational activities in accordance with the ACCME's Essential Areas and Policies to ensure balance, independence, objectivity and scientific rigor. In accordance with the ACCME's 2004 Standards for Commercial Support, everyone who is in a position to control the content of an educational activity certified for AMA PRA Category 1 Credit™ is required to disclose all relevant financial relationships with any commercial interests within the past 12 months that creates a real or apparent conflict of interest. Individuals who do not disclose are disqualified from participating in a CME activity. Individuals with potential for influence or control of CME content include planners and planning committee members, authors, teachers, educational activity directors, educational partners, and others who participate, e.g. facilitators and moderators. This disclosure pertains to relationships with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic. Any real or apparent conflicts of interest related to the content of the presentations must be resolved prior to the educational activity. Disclosure of off-label, experimental or investigational use of drugs or devices must also be made known to the audience.